Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Cassava Sciences (NASDAQ:SAVA) Shares Down 3.8% | news.google.com • |
Cassava Sciences stock gains on pact with ex-CEO (NASDAQ:SAVA) | news.google.com • |
Cassava Sciences (NASDAQ:SAVA) Trading Up 10.8% | news.google.com • |
(SAVA) Technical Pivots with Risk Controls | news.google.com • |
Is Sava, druzba za upravljanje in financiranje, d.d.'s (LJSE:SAVR) Stock Price Struggling As A Result Of Its Mixed Financials? | news.google.com • |
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference | globenewswire.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-05 | 2024-09 | -1.37 | N/A | N/A | N/A |
2024-08-08 | 2024-06 | -0.44 | -1.28 | -0.84 | -190.91% |
2024-05-10 | 2024-03 | -0.51 | -1.41 | -0.9 | -176.47% |
2024-02-28 | 2023-12 | -0.4 | -0.5 | -0.1 | -25.00% |
2023-11-07 | 2023-09 | -0.9 | -0.61 | 0.29 | 32.22% |
2023-08-03 | 2023-06 | -0.58 | -0.63 | -0.05 | -8.62% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-07 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-07-05 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-10 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-08 | HC Wainwright & Co. | Upgrade | Buy | |
2023-03-05 | HC Wainwright & Co. | Upgrade | Buy | |
2023-01-23 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2018-10-02 | ARMISTICE CAPITAL L.L.C. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2023-05-23 | BARBIER REMI | Chief Executive Officer | 0.00 | Conversion of Exercise of derivative security |
2024-04-22 | BARRY RICHARD J | Director | 0.00 | Conversion of Exercise of derivative security |
2022-10-02 | FRIEDMANN NADAV | Officer and Director | 80.05K | Conversion of Exercise of derivative security |
2023-04-30 | GUSSIN ROBERT Z | Director | 10.62K | Conversion of Exercise of derivative security |
2024-04-17 | KUPIEC JAMES WILLIAM | Officer | 4.00K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 2.75M | 67.35M | 6.54% |
2023-06-29 | Vanguard Group Inc | 2.25M | 55.16M | 5.36% |
2023-06-29 | State Street Corporation | 952.09K | 23.35M | 2.27% |
2023-06-29 | Geode Capital Management, LLC | 803.31K | 19.70M | 1.91% |
2023-06-29 | Gallacher Capital Management LLC | 583.29K | 14.30M | 1.39% |
2023-06-29 | Northern Trust Corporation | 370.64K | 9.09M | 0.88% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 1.23M | 30.21M | 2.94% |
2023-08-30 | iShares Russell 2000 ETF | 908.42K | 19.05M | 2.16% |
2023-06-29 | Vanguard Extended Market Index Fund | 542.35K | 13.30M | 1.29% |
2023-07-30 | Fidelity Small Cap Index Fund | 353.09K | 7.76M | 0.84% |
2023-08-30 | iShares Russell 2000 Growth ETF | 333.17K | 6.99M | 0.79% |
2023-05-30 | Fidelity Extended Market Index Fund | 202.34K | 4.60M | 0.48% |
Dividend | Date |
---|---|
0.75 | 2012-12-13 |
2 | 2010-12-13 |
Split | Date |
---|---|
1 : 7 | 2017-05-10 |
-
-
$SAVA - nothing new here, just standard movement on our way up… keep buying and holding, long term wealth building happening here!!
-
Looks like shorts are returning shares in droves. Rumour SEC settlement coming.
-
The problème is no body is buying til sec read out or p3. it’s easy for the short to do what they do best.
We need a uge catalyst to break the short.
The only buyer is that one who wanna reduce their sp cause there bagholder since 2 years and sell a couple off share in case off bad report and that help the short
Just my 2 cents
-
$31.50 resistance testing again… $SAVA
-
Green by days end, get in now… $SAVA
-
$SAVA - consolidating like a hurricane in warm open water. I have seen numbers around $27.89 buy to $28. This will get back into the green after some more consolidation.
-
$SAVA - you don’t lose until you sell. You need to buy for the “long” haul - Buy long and hold, hold, hold.
-
$SAVA - hold on tight to your shares newbies!! Hold tight! Rewards to come for those that wait!!!
-
$SAVA without the presence of volume trading i.e. buying shares, this will go back down to where it was yesterday. Shorts are just doing their laborious daily price management games. Don’t play unless you intend to buy and hold, otherwise, you will lose…
-
$SAVA remember this is not $CAVA. $CAVA is what you really want…..
-
-
$SAVA - watching this price action, my thoughts are that Cassava Sciences stock couldn’t be in a more stable upward trend.. The swings mean nothing while it maintains its overall upward path. Don’t be fooled by any news articles or posts, SAVA is solid - hold your shares with all you have…
-
$SAVA, Add a share today!!
-
$SAVA - dont forget 3-days last week -$4 each day… this can run if retail shows up and starts accumulating…
-
$SAVA dont be to satisfied with the minuscule movement, we should be over $52 but for shorts and WS banks criminal activity. Everyone should buy what they can afford and screw them all..
-
Cassava Sciences (NASDAQ:SAVA) Shares Down 3.8%
news.google.com • -
Cassava Sciences stock gains on pact with ex-CEO (NASDAQ:SAVA)
news.google.com • -
Cassava Sciences (NASDAQ:SAVA) Trading Up 10.8%
news.google.com • -
(SAVA) Technical Pivots with Risk Controls
news.google.com • -
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
globenewswire.com • -
Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
marketbeat.com • -
Cassava Sciences Q2 Earnings Review: So Many Questions, So Few Answers
seekingalpha.com • -
2 Biotech Stocks Making Moves Today
schaeffersresearch.com • -
Cassava Sciences News: Why Is SAVA Stock Trending Today?
investorplace.com • -
Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson
globenewswire.com • -
Get Your Money Out of These 3 Healthcare Stocks ASAP
investorplace.com • -
SAVA Stock: Cassava Sciences Extends Simufilam Trials as Much as 36 Months
investorplace.com • -
Cassava Sciences Announces Expansion of Open-Label Extension Trials
globenewswire.com • -
Get Your Money Out of These 3 Biotech Stocks Before the End of July
investorplace.com • -
SAVA Stock Alert: Cassava Sciences Pops on Late-Stage Trial Update
investorplace.com • -
SAVA Stock Plunges as Cassava Sciences CEO Steps Down. What to Know.
investorplace.com • -
3 Healthcare Stocks to Sell in July Before They Crash & Burn
investorplace.com • -
Top 5 Health Care Stocks That May Explode In July
benzinga.com • -
3 Biotech Stocks to Sell in July Before They Crash & Burn
investorplace.com • -
Why Cassava Sciences Stock Is Sinking Today
fool.com •